New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19

New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19

Submitted by admin on July 1, 2020 - 10:56am
Source: 
Pharmaforum
News Tags: 
artificial intelligence
machine learning
BenevolentAI
Eli Lilly
olumiant
COVID-19
Headline: 
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
snippet: 

AI and machine learning drug development firm BenevolentAI has highlighted further data supporting its hypothesis that Eli Lilly’s Olumiant (baricitinib) could be a potential treatment for COVID-19.

Do Not Allow Advertisers to Use My Personal information